{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:21:51Z","timestamp":1793726511764,"version":"4.6.1"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuron loss in the substantia nigra, which is accompanied by immune dysfunction and chronic inflammation. Peripheral monocytes, key players in systemic inflammation, cross the blood-brain barrier and alter PD etiology and progression. To define the role of peripheral monocytes, cross-sectional studies of RNA transcripts isolated from PD monocytes were compared with age- and sex-matched control monocytes. After stratification by Hoehn &amp;amp; Yahr (H&amp;amp;Y) stage, inflammatory transcripts IL-6, IL-1\u03b2, ARG1, CD163, and CCR2 were upregulated in PD monocytes and increased with disease burden. Furthermore, PPARGC1A (PGC-1\u03b1), GPX4, NFE2L2 (NRF2), and SIRT3 decreased with increasing disease burden, while only SIRT1 expression increased, reflecting oxidative stress and mitochondrial dysregulation. Overall, the PD monocyte transcripts correlated with PD disease burden as monitored by H&amp;amp;Y, UPDRS total, UPDRS Part 3, ADL, and disease duration. This study demonstrated that dysregulation of inflammation and oxidative stress pathways contributed to disease progression in PD. Monocytes may serve as biomarkers for tracking clinical symptoms and could be leveraged as targets for therapeutic intervention.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1571074","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T05:37:39Z","timestamp":1753249059000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Peripheral monocyte transcriptional signatures of inflammation and oxidative stress in Parkinson\u2019s disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Aaron D.","family":"Thome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Atassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Thonhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Faridar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Beers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene C.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley H.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of parkinson disease: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00006-X","article-title":"Targeting alpha-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations","volume":"14","author":"Dehay","year":"2015","journal-title":"Lancet Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/35081564","article-title":"Alpha-synuclein and neurodegenerative diseases","volume":"2","author":"Goedert","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25111","article-title":"Inflammation in Parkinson's disease: cause or consequence","volume":"27","author":"Appel","year":"2012","journal-title":"Mov Disord"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.855776","article-title":"Pre-clinical studies identifying molecular pathways of neuroinflammation in parkinson's disease: A systematic review","volume":"14","author":"Fathi","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adk3225","article-title":"Central and peripheral innate and adaptive immunity in Parkinson's disease","volume":"15","author":"Harms","year":"2023","journal-title":"Sci Transl Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1476461","article-title":"The emerging role of disease-associated microglia in Parkinson's disease","volume":"18","author":"Samant","year":"2024","journal-title":"Front Cell Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/bs.pbr.2019.10.006","article-title":"Innate and adaptive immune responses in Parkinson's disease","volume":"252","author":"Schonhoff","year":"2020","journal-title":"Prog Brain Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29363","article-title":"Brain and systemic inflammation in de novo parkinson's disease","volume":"38","author":"Yacoubian","year":"2023","journal-title":"Mov Disord"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-13-9913-8_13","article-title":"Microglia in parkinson's disease","volume":"1175","author":"Ho","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci Lett"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci Lett"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson's disease","volume":"9","author":"Blesa","year":"2015","journal-title":"Front Neuroanat"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson's disease","volume":"3","author":"Dias","year":"2013","journal-title":"J Parkinsons Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13041-017-0340-9","article-title":"Oxidative stress and cellular pathologies in Parkinson's disease","volume":"10","author":"Puspita","year":"2017","journal-title":"Mol Brain"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae177","article-title":"The immune system in Parkinson's disease: what we know so far","volume":"147","author":"Roodveldt","year":"2024","journal-title":"Brain"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.2742","article-title":"Aberrations in peripheral inflammatory cytokine levels in parkinson disease: A systematic review and meta-analysis","volume":"73","author":"Qin","year":"2016","journal-title":"JAMA Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","article-title":"Peripheral cytokines profile in Parkinson's disease","volume":"23","author":"Reale","year":"2009","journal-title":"Brain Behav Immun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00303","article-title":"Autoimmunity in parkinson's disease: the role of alpha-synuclein-specific T cells","volume":"10","author":"Garretti","year":"2019","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12974-021-02296-8","article-title":"T-cell dysregulation is associated with disease severity in Parkinson's Disease","volume":"18","author":"Bhatia","year":"2021","journal-title":"J Neuroinflammation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.21037\/atm.2019.10.105","article-title":"Abnormal subpopulations of peripheral blood lymphocytes are involved in Parkinson's disease","volume":"7","author":"Sun","year":"2019","journal-title":"Ann Transl Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41531-021-00188-5","article-title":"Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson's disease","volume":"7","author":"Thome","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11190-z","article-title":"Changes of T lymphocyte subpopulations and their roles in predicting the risk of Parkinson's disease","volume":"269","author":"He","year":"2022","journal-title":"J Neurol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2012.07.015","article-title":"Reduced T helper and B lymphocytes in Parkinson's disease","volume":"252","author":"Stevens","year":"2012","journal-title":"J Neuroimmunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001036","article-title":"Dysregulation of the adaptive immune system in patients with early-stage parkinson disease","volume":"8","author":"Yan","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1994.tb02699.x","article-title":"Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood","volume":"90","author":"Fiszer","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.2019.49.issue-3","article-title":"Immune system responses in Parkinson's disease: Early and dynamic","volume":"49","author":"Tansey","year":"2019","journal-title":"Eur J Neurosci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"10757","DOI":"10.1038\/s41598-018-28986-7","article-title":"A monocyte gene expression signature in the early clinical course of Parkinson's disease","volume":"8","author":"Schlachetzki","year":"2018","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/mds.v34.11","article-title":"Alterations in blood monocyte functions in parkinson's disease","volume":"34","author":"Nissen","year":"2019","journal-title":"Mov Disord"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-014-1345-4","article-title":"Inflammatory dysregulation of blood monocytes in Parkinson's disease patients","volume":"128","author":"Grozdanov","year":"2014","journal-title":"Acta Neuropathol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11258-w","article-title":"Dysregulation of peripheral monocytes and pro-inflammation of alpha-synuclein in Parkinson's disease","volume":"269","author":"Su","year":"2022","journal-title":"J Neurol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1042\/BST20201091","article-title":"The interplay between monocytes, alpha-synuclein and LRRK2 in Parkinson's disease","volume":"51","author":"Strader","year":"2023","journal-title":"Biochem Soc Trans"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/science.1249547","article-title":"Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes","volume":"344","author":"Raj","year":"2014","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-021-00110-x","article-title":"Dysregulation of mitochondrial and proteolysosomal genes in Parkinson's disease myeloid cells","volume":"1","author":"Navarro","year":"2021","journal-title":"Nat Aging"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5610-12.2013","article-title":"MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration","volume":"33","author":"Harms","year":"2013","journal-title":"J Neurosci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2017.11.010","article-title":"Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease","volume":"300","author":"Harms","year":"2018","journal-title":"Exp Neurol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"816460","DOI":"10.1155\/2015\/816460","article-title":"Understanding the mysterious M2 macrophage through activation markers and effector mechanisms","volume":"2015","author":"Roszer","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2795090","DOI":"10.1155\/2016\/2795090","article-title":"The reactive oxygen species in macrophage polarization: reflecting its dual role in progression and treatment of human diseases","volume":"2016","author":"Tan","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/cr.2013.75","article-title":"ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages","volume":"23","author":"Zhang","year":"2013","journal-title":"Cell Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28424","article-title":"Soluble CD163 changes indicate monocyte association with cognitive deficits in parkinson's disease","volume":"36","author":"Nissen","year":"2021","journal-title":"Mov Disord"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2004.08.016","article-title":"Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease","volume":"370","author":"Huerta","year":"2004","journal-title":"Neurosci Lett"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/ene.v30.10","article-title":"Collaborative plasma biomarkers for Parkinson disease development and progression: A cross-sectional and longitudinal study","volume":"30","author":"Jiao","year":"2023","journal-title":"Eur J Neurol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh655","article-title":"Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis","volume":"129","author":"Mahad","year":"2006","journal-title":"Brain"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2917","article-title":"Microglia and monocytes: 'tis plain the twain meet in the brain","volume":"14","author":"Ransohoff","year":"2011","journal-title":"Nat Neurosci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nature09615","article-title":"The myeloid cells of the central nervous system parenchyma","volume":"468","author":"Ransohoff","year":"2010","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13073-021-00863-5","article-title":"Microglial PGC-1alpha protects against ischemic brain injury by suppressing neuroinflammation","volume":"13","author":"Han","year":"2021","journal-title":"Genome Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.arr.2018.03.004","article-title":"PGC-1alpha sparks the fire of neuroprotection against neurodegenerative disorders","volume":"44","author":"Lv","year":"2018","journal-title":"Ageing Res Rev"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1452696","DOI":"10.1155\/2020\/1452696","article-title":"PGC-1alpha, inflammation, and oxidative stress: an integrative view in metabolism","volume":"2020","author":"Rius-Perez","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.317957","article-title":"Deciphering the role of PGC-1alpha in neurological disorders: from mitochondrial dysfunction to synaptic failure","volume":"17","author":"Panes","year":"2022","journal-title":"Neural Regener Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2015.07.025","article-title":"Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight","volume":"74","author":"Bhat","year":"2015","journal-title":"BioMed Pharmacother"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9070597","article-title":"The role of oxidative stress in parkinson's disease","volume":"9","author":"Chang","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6_Suppl_3.161S","article-title":"Oxidative stress and the pathogenesis of Parkinson's disease","volume":"47","author":"Jenner","year":"1996","journal-title":"Neurology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson's disease","author":"Subramaniam","year":"2013","journal-title":"Prog Neurobiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13024-023-00691-8","article-title":"Microglial ferroptotic stress causes non-cell autonomous neuronal death","volume":"19","author":"Liddell","year":"2024","journal-title":"Mol Neurodegener"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814108","article-title":"The role of cellular defense systems of ferroptosis in parkinson's disease and alzheimer's disease","volume":"24","author":"Chu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-023-03646-8","article-title":"Oxytosis\/ferroptosis in neurodegeneration: the underlying role of master regulator glutathione peroxidase 4 (GPX4)","volume":"61","author":"Dar","year":"2024","journal-title":"Mol Neurobiol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10111649","article-title":"NRF2 activation and downstream effects: focus on parkinson's disease and brain angiotensin","volume":"10","author":"Parga","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2020.0216","article-title":"The critical role of SIRT1 in parkinson's disease: mechanism and therapeutic considerations","volume":"11","author":"Li","year":"2020","journal-title":"Aging Dis"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04486-w","article-title":"Is SIRT3 and mitochondria a reliable target for parkinson's disease and aging? A narrative review","volume":"62","author":"Kandy","year":"2024","journal-title":"Mol Neurobiol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"110928","DOI":"10.1016\/j.biopha.2020.110928","article-title":"Regulation of SIRT3 on mitochondrial functions and oxidative stress in Parkinson's disease","volume":"132","author":"Shen","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2023.1272118","article-title":"Sex and gender affect immune aging","volume":"4","author":"Calabro","year":"2023","journal-title":"Front Aging"},{"key":"B65","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41467-020-14396-9","article-title":"Sexual-dimorphism in human immune system aging","volume":"11","author":"Marquez","year":"2020","journal-title":"Nat Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076302","article-title":"Gender-specific impact of sex hormones on the immune system","volume":"24","author":"Sciarra","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B67","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41531-021-00180-z","article-title":"Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease","volume":"7","author":"Carlisle","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1038\/s41467-019-12348-6","article-title":"ImmGen report: sexual dimorphism in the immune system transcriptome","volume":"10","author":"Gal-Oz","year":"2019","journal-title":"Nat Commun"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12796","article-title":"Gender differences in Parkinson's disease: A clinical perspective","volume":"136","author":"Georgiev","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"B71","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","article-title":"Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-naive and drug-treated patients","volume":"15","author":"Kustrimovic","year":"2018","journal-title":"J Neuroinflammation"},{"key":"B72","doi-asserted-by":"publisher","first-page":"33738","DOI":"10.1038\/srep33738","article-title":"Dopaminergic receptors on CD4+ T naive and memory lymphocytes correlate with motor impairment in patients with parkinson's disease","volume":"6","author":"Kustrimovic","year":"2016","journal-title":"Sci Rep"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-017-9726-9","article-title":"Dopamine increases CD14(+)CD16(+) monocyte transmigration across the blood brain barrier: implications for substance abuse and HIV neuropathogenesis","volume":"12","author":"Calderon","year":"2017","journal-title":"J Neuroimmune Pharmacol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117450","article-title":"Dopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesis","volume":"10","author":"Coley","year":"2015","journal-title":"PloS One"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2016.167","article-title":"Therapeutic implications of brain-immune interactions: treatment in translation","volume":"42","author":"Miller","year":"2017","journal-title":"Neuropsychopharmacology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1571074\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T05:37:40Z","timestamp":1753249060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1571074\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":75,"alternative-id":["10.3389\/fimmu.2025.1571074"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1571074","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"article-number":"1571074"}}